Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satya Dash

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Diabetes, Obesity & Metabolism|February 12, 2019
Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adultsPriska Stahel, So Jeong Lee, Shawn K Sud, et al.
Diabetes, Obesity & Metabolism|August 1, 2019
Glucagon-like peptide-2 mobilizes lipids from the intestine by a systemic nitric oxide-independent mechanismChangting Xiao, Priska Stahel, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2012
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humansChangting Xiao, Robert H J Bandsma, Satya Dash, et al.
The Journal of Nutrition, Health & Aging|May 9, 2025
A non-fasting marker of metabolic syndrome in a high-risk populationSabrina Cancelliere, Tracy Heung, Christina Blagojevic, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 11, 2025
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline updateSue D Pedersen, Priya Manjoo, Satya Dash, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 29, 2025
Sue D Pedersen, Priya Manjoo, Satya Dash, et al.
Diabetes|June 24, 2022
Insulin Response to Oral Glucose and Cardiometabolic Disease: A Mendelian Randomization Study to Assess Potential CausalityAnthony Nguyen, Rana Khafagy, Ameena Meerasa, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Evaluation of the specific effects of intranasal glucagon on glucose production and lipid concentration in healthy men during a pancreatic clampSatya Dash, Changting Xiao, Priska Stahel, et al.
Diabetes, Obesity & Metabolism|March 15, 2024
Analyses of potential causal contributors to increased waist/hip ratio-associated cardiometabolic disease: A combined and sex-stratified Mendelian randomization studyHabiba Hashemy, Anthony Nguyen, Rana Khafagy, et al.
Diabetes Research and Clinical Practice|December 6, 2011
Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusionSatya Dash, Sarah Crisp, Sara Hartnell, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Diabetes, Obesity & Metabolism|February 12, 2019
Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adultsPriska Stahel, So Jeong Lee, Shawn K Sud, et al.
Diabetes, Obesity & Metabolism|August 1, 2019
Glucagon-like peptide-2 mobilizes lipids from the intestine by a systemic nitric oxide-independent mechanismChangting Xiao, Priska Stahel, Cecilia Morgantini, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 12, 2012
Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humansChangting Xiao, Robert H J Bandsma, Satya Dash, et al.
The Journal of Nutrition, Health & Aging|May 9, 2025
A non-fasting marker of metabolic syndrome in a high-risk populationSabrina Cancelliere, Tracy Heung, Christina Blagojevic, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 11, 2025
Pharmacotherapy for obesity management in adults: 2025 clinical practice guideline updateSue D Pedersen, Priya Manjoo, Satya Dash, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 29, 2025
Sue D Pedersen, Priya Manjoo, Satya Dash, et al.
Diabetes|June 24, 2022
Insulin Response to Oral Glucose and Cardiometabolic Disease: A Mendelian Randomization Study to Assess Potential CausalityAnthony Nguyen, Rana Khafagy, Ameena Meerasa, et al.
Diabetes, Obesity & Metabolism|July 22, 2017
Evaluation of the specific effects of intranasal glucagon on glucose production and lipid concentration in healthy men during a pancreatic clampSatya Dash, Changting Xiao, Priska Stahel, et al.
Diabetes, Obesity & Metabolism|March 15, 2024
Analyses of potential causal contributors to increased waist/hip ratio-associated cardiometabolic disease: A combined and sex-stratified Mendelian randomization studyHabiba Hashemy, Anthony Nguyen, Rana Khafagy, et al.
Diabetes Research and Clinical Practice|December 6, 2011
Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusionSatya Dash, Sarah Crisp, Sara Hartnell, et al.
Pageof 7